PTGS2 and mastitis: LEO attenuated inflammatory responses, which was supported by decreasing TNF-α and IL-1β production in LPS-treated microglia, inhibiting COX-2 mRNA and protein expression in LPS-induced mouse mastitis [32,33,34].